The European Court of Justice last week turned back an effort by several countries to weaken the protections on biotechnology patents, confirming the legal basis of Directive 98/44/EC, which protects biotechnological inventions.

The Netherlands originally brought the case, which was later joined by Italy and Norway, because of objections to potential patenting on genes, plants, animals and body parts. In rejecting the challenge, the EU court found that the